Kyle Moran - 11 Oct 2024 Form 4 Insider Report for Wave Life Sciences Ltd. (WVE)

Role
Chief Financial Officer
Signature
/s/ Kyle Moran
Issuer symbol
WVE
Transactions as of
11 Oct 2024
Transactions value $
$62,000
Form type
4
Filing time
11 Oct 2024, 20:00:04
Previous filing
27 Sep 2024
Next filing
06 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WVE Ordinary Shares Options Exercise $62K +25K +126.41% $2.48 44.8K 11 Oct 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WVE Share Option (right to buy) Options Exercise $0 -25K -100% $0.00 0 11 Oct 2024 Ordinary Shares 25K $2.48 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The share options that were exercised via cash purchase in this reportable transaction were fully vested.